Highlights d The oncogenic Gas mutation R201C allows GDP-bound Gas to activate adenylyl cyclase d GDP-bound Gas(R201C/C237S) adopts an active state in its crystal structure 
INTRODUCTION
GTPase proteins are the transducers of transmembrane receptor cascades serving as timers of signaling through adoption of a transiently active GTP-bound state. Termination of signaling is achieved through intrinsic GTPase activity or heterodimerization with GTPase activating proteins (GAPs) accelerating hydrolysis of GTP to GDP, causing a conformational change producing a GDP-bound species that loses the ability to bind and activate downstream effectors (Gilman, 1995) . Inherited and somatic mutations of GTPases are the causal basis of a wide assortment of disease states. The KRAS gene, which encodes the small GTPase K-Ras, is the most frequently activated oncogene in cancer. Mutations at the G12 position of K-Ras lock K-Ras in its GTP-bound active state through disturbing the ''arginine finger'' that is provided by GAPs thereby disrupting the transition state for GTP hydrolysis (Bourne, 1997; Rodenhuis et al., 1987; Scheffzek et al., 1997) . The most frequently mutated heterotrimeric G protein in cancer is Gas encoded by GNAS. Gain-offunction mutations in Gas cause growth hormone (GH)-secreting pituitary tumors and other cAMP-dependent tumors (Landis et al., 1989; O'Hayre et al., 2013; Vallar et al., 1987) . More than half of these mutations in Gas occur at a single hotspot, R201, which serves as the ''arginine finger'' in Gas (O'Hayre et al., 2013) . Unlike K-Ras, this ''arginine finger'' is built into Gas instead of being provided by GAPs, but in an analogous fashion to Ras mutations, the R201 mutations decrease the GTP hydrolysis rate, thereby maintaining Gas in a GTP-bound active state (Sprang, 2016) .
The analyses of the role of activating mutations in K-Ras and Gas have presumed the canonical view that GTP is required for the proteins to adopt the active conformation and stimulate downstream effectors, and the GDP-bound state is not of relevance to positive signaling. While this is most certainly appropriate for the small GTPase K-Ras, we wondered if the G protein mutations may influence the GDP state. Because R201 is an intramolecular arginine finger, its presence in the nucleotide pocket in the GDP-bound state could afford a layer of control over the GDP-bound conformation that may be disrupted by the oncogenic R201C hotspot mutation. Indeed, through structural and functional analysis of the R201C Gas gain-of-function mutation we uncovered the unprecedented ability of the protein to activate its downstream effector adenylyl cyclase while binding to GDP even in the presence of Gbg subunits. We ascribe this behavior to the involvement of R201 in maintaining GDP-bound Gas in an off state through destabilization of an intramolecular hydrogen bond network (H-bond network).
Having found that a gain-of-function mutation can convert GDP into an activator, we postulated that a loss-of-function mutation might disrupt the normal role of GTP. Loss-of-function mutations in the H-bond network of Gas that cause pseudohypoparathyroidism (PHP-Ia) have been ascribed to defects in GTP binding as well as hyper GTPase activity. As our analysis of R201C revealed the paradoxical effect of the H-bond network on the GDP state, we wondered if loss-of-function mutations might destabilize the GTP state. Indeed, we identified R228C Gas that has wild-type (WT)-like ability to bind and hydrolyze GTP yet is compromised in its ability to stimulate adenylyl cyclase when a non-hydrolyzable GTP analog is bound. These studies reveal a new molecular mechanism for the diverse disease-causing mutations in Gas and uncover the importance of a H-bond network in G protein activation and inactivation.
RESULTS
The GDP Dissociation Rate of the R201C Mutant of Gas Is Slower Than Its GTP Hydrolysis Rate The R201C mutation was reported to disrupt the GTPase activity of Gas (Landis et al., 1989) . We confirmed this using a single turnover GTP hydrolysis assay. WT human Gas and the R201C mutant were overexpressed in E. coli and purified to homogeneity ( Figure S1A ), and their GTPase activities were measured (Figures 1A and 1B) . WT Gas exhibited an intrinsic GTP hydrolysis rate (k cat ) of 1.183 ± 0.074 min À1 at 0 C. The hydrolysis of GTP by the R201C mutant was too slow to be measured at 0 C, so instead, it was measured at 20 C (0.020 ± 0.003 min À1 ).
The R201C mutation does not completely disrupt the GTPase activity of Gas. In line with this, we found that both WT and R201C Gas purified from E. coli were in a GDP-bound state ( Figure S1B ). GDP dissociation is the rate-limiting step in the process of GDP-GTP exchange (Gilman, 1987) . We evaluated the GDP dissociation rates (k off ) of WT Gas and the R201C mutant in buffers containing different concentrations of MgCl 2 and 1 mM EDTA. The concentrations of free Mg 2+ were calculated using a method described previously (Higashijima et al., 1987c) (also see the STAR Methods). Mg 2+ was reported to increase the GTP binding affinity of Ga proteins, but had less effect on GDP binding (Higashijima et al., 1987c) ; in agreement with this, we found that the k off of WT Gas was only slightly decreased by increasing the free Mg 2+ concentration from 1 mM (1 mM EDTA + 0.5 mM MgCl 2 ) to 3.6 mM (1 mM EDTA + 5 mM MgCl 2 ) ( Figure 1C ). In contrast, the k off of the R201C mutant exhibited a quite different dependence on the Mg 2+ concentration: it was nearly 5 times that of WT Gas at a low Mg 2+ concentration (1 mM EDTA + 0.5 mM MgCl 2 ), but was decreased Figure 1 . Characterization of the R201C Mutant of Gas (A and B) The single turnover GTP hydrolysis rates (k cat ) of wild-type (WT) Gas (A) and the R201C mutant (B) ]GDP was assayed in a buffer containing 1 mM EDTA, 0.5 mM GDP, and the indicated concentration of MgCl 2 with or without 1 mM Gb/g(C68S). The data represent the mean ± SD of three independent measurements. (D) The changes in the intrinsic tryptophan fluorescence of WT Gas and the R201C mutant caused by binding of GNP, or binding and hydrolysis of GTP. 5 mM GDP-bound Gas was mixed with 0.5 mM GNP or GTP in a buffer containing 1 mM EDTA and 0.1 mM MgCl 2 to initiate the nucleotide exchange. After 1 hr, MgCl 2 was added to a final concentration of 2.5 mM to decrease the GDP dissociation rates. (E) Evaluation of the GTP occupancy of the R201C mutant in the presence of excess GTP. Figure S1 .
to $1/3 of that of WT Gas when the free Mg 2+ concentration increased to 1.2 mM (1 mM EDTA + 2.5 mM MgCl 2 ) and further decreased at a free Mg 2+ concentration of 3.6 mM (1 mM EDTA + 5 mM MgCl 2 ) ( Figure 1C ). In the cytoplasm of mammalian cells, the free Mg 2+ concentration has been estimated to be 0.5-1 mM, with an additional 4-5 mM Mg 2+ being in complex with phosphonucleotides and phosphometabolites, which represents a large Mg 2+ pool (Romani, 2011) . As a result, under physiological conditions, the R201C mutation is anticipated to significantly decrease the k off of Gas. The presence of Gbg subunits reduced the k off of both WT Gas and the R201C mutant ( Figure 1C ). The R201C mutant exhibits a GDP-GTPgS exchange rate (k app ) slower than that of WT Gas in the presence of 2.5 mM MgCl 2 and 1 mM EDTA ( Figure S1C ), consistent with the k off values.
Based on the measured rate constants for the individual steps in the GTPase cycle, it is possible to calculate the fraction of R201C Gas bound to each nucleotide. In the presence of excess GTP, when the cycle of GTP binding, hydrolysis, and GDP release reaches equilibrium, the fraction of Ga proteins occupied by GTP is less than k off /(k off + k cat ). In the presence of 2.5 mM MgCl 2 and 1 mM EDTA, <32% of R201C is calculated to be in the GTP state without stimulation by guanine nucleotide exchange factors (GEFs), and Gbg subunits can further lower the ratio to $11%.
To experimentally measure the differences between WT Gas and the R201C mutant in terms of both the GDP-GTP exchange and GTP hydrolysis steps, we turned to intrinsic tryptophan fluorescence that has been used to monitor nucleotide exchange of G proteins, such as Gao (Higashijima et al., 1987b) and Gat (Phillips and Cerione, 1988) . During replacement of GDP by GTP, three regions of G proteins, named switch I, II, and III, undergo significant conformational changes (Lambright et al., 1994) , resulting in an increase in the intrinsic tryptophan fluorescence; thus, the change in tryptophan fluorescence can be used to quantify the ratio of Gas that associates with GTP. GDPbound WT Gas and the R201C mutant were incubated with excess GTP or its non-hydrolysable analog GNP (guanosine 5 0 -[b,g-imido]triphosphate) (500 mM) in a buffer containing 0.1 mM free Mg 2+ (1 mM EDTA + 0.1 mM MgCl 2 ) to facilitate nucleotide exchange; after 1 hr, the concentration of MgCl 2 was increased to 2.5 mM ($1 mM free Mg 2+ in the buffer, which is close to the concentration of cytoplasmic-free Mg 2+ ).
In the presence of GNP, the tryptophan fluorescence of WT Gas increased nearly 40% but had not reached its maximum following a 1-hr incubation; the fluorescence of the R201C mutant increased $55% to reach its maximum after 30 min, much faster than that of WT Gas, indicating a faster rate of GNP binding ( Figure 1D ). The changes of the fluorescence before additional MgCl 2 was added were consistent with the GDP dissociation data at a low Mg 2+ concentration (0.5 mM MgCl 2 + 1 mM EDTA) ( Figure 1C ). In the presence of GTP, the fluorescence of WT Gas did not increase but slightly decreased over time, which can be explained by the fast k cat and slow k off of WT Gas; the slight decrease of tryptophan fluorescence is probably due to fluorescence quenching. Before MgCl 2 concentration was increased, the fluorescence of the R201C mutant in the presence of GTP increased similarly to that in the presence of GNP, consistent with the fast k off and relatively slow k cat of the R201C mutant at a low Mg 2+ concentration; but after the MgCl 2 concentration was increased to 2.5 mM, the R201C fluorescence significantly decreased over time and was close to the fluorescence of WT Gas after 4 hr ( Figure 1D ), because the k off of the R201C mutant under this condition is slower than the k cat . These data support our calculation that the R201C mutant is not locked in a GTPbound state even in the presence of excess GTP, despite its significant loss of GTPase activity.
To validate the nucleotide state predicted based on tryptophan fluorescence, we turned to a [g-32 P]GTP binding assay ( Figure 1E ). The R201C mutant was pre-incubated in a low Mg 2+ buffer (1 mM EDTA + 0.1 mM MgCl 2 ) with 400 mM GTP that is close to the physiological concentration of GTP (Traut, 1994) ; 20 nM [g-32 P]GTP was added as an internal standard.
After the binding of [g-32 P]GTP to the R201C mutant reached a maximum, the concentration of free Mg 2+ was increased to about 1.1 mM (1 mM EDTA + 2.5 mM MgCl 2 ) and the changes of bound [g-32 P]GTP with time were measured. The bound [g- 32 P]GTP decreased to $30% of the maximum after 4 hr, which can be explained by the faster GTP hydrolysis than GDP dissociation. When Gbg subunits were added together with MgCl 2 (Gbg:Gas = 1.5:1, molar ratio), the bound [g-32 P]GTP further decreased to below 10% of the maximum after 4 hr, which supports the finding that Gbg subunits decrease the rate of GDP dissociation ( Figure 1C ). In contrast, when the free Mg 2+ concentration was kept at 0.1 mM (1 mM EDTA + 0.1 mM MgCl 2 ), the bound [g-
32
P]GTP only slowly decreased to $80% of the maximum, which may be due to the instability of the R201C mutant in the low Mg 2+ buffer. These in vitro assays demonstrate that the R201C mutant is not locked in the GTP state, instead, without GEF stimulation it would be mainly in the GDP state in cells considering that the presence of Gbg subunits and millimolar Mg 2+ dramatically decrease the rate of GDP dissociation. This conclusion is supported by a previously published cellular study, in which the authors showed an increase of the adenylyl cyclaseactivating activity of the R201C mutant when b-adrenergic receptor (b-AR) was stimulated by isoproterenol (Landis et al., 1989) . If R201C was in a persistent GTP-bound state, such a b-AR agonist would not be able to stimulate R201C Gas signaling.
Crystal Structure of GDP-Bound Gas(R201C/C237S) The GDP dissociation assay indicates that the R201C mutation not only decreases the GTP hydrolysis rate of Gas, but may also changes the protein conformation to affect the Mg 2+ and nucleotide binding properties. We attempted to solve the crystal structure of the R201C mutant in a GDP-bound state. Failure to obtain suitably diffracting crystals led us to consider modifications to the protein to aid crystallization. We performed a screen for oxidizable cysteine residues, because free cysteines on the protein surface often complicate crystallization and found that mutating C237 to serine enabled crystallization of the R201C mutant. Gas(C237S) and Gas(R201C/C237S) behaved the same as WT Gas and the R201C mutant, respectively, in the GDP dissociation assay ( Figures S2A and S2B ), GTPgS binding assay ( Figures S1C and S2C ), and tryptophan fluorescence assay ( Figures 1D and S2D ). The structure of Gas(R201C/C237S) was determined by molecular replacement and refined to 1.7 Å (Table S1 ). The overall structure is shown in Figure 2A . Three switch regions and the two mutant residues, C201 and S237, are highlighted. In the nucleotide binding pocket, a Mg 2+ ion coordinates with the b phosphate of GDP, the side chain of S54, and four water molecules; one of the four water molecules interacts with D223 at the N terminus of switch II through two hydrogen bonds (Figures 2B and S3A) .
We attempted to overlay our structure with the crystal structure of a G protein in the GDP-bound state. No structure of GDP-bound Gas has been reported, so instead, we used the structure of GDP-bound WT Gai1 in the crystal structure of Gai1/Gb1/g2 heterotrimer (PDB: 1GP2) (Wall et al., 1995) , in which switch II and III of Gai1 are stabilized by Gb1/g2 in a fully inactive conformation. Gai1 shares a sequence identity of 41% with Gas used in our study. The conformation of the switch regions in our GDP-bound Gas(R201C/C237S) structure is quite different from the inactive conformation ( Figure 2C ). Specifically, in our structure the N terminus of switch II is well folded as an a-helix and closely interacts with switch III; but in the inactive conformation represented by the GDP-bound Gai1(WT) structure, the N terminus of switch II is unstructured and is far from switch III ( Figure 2D ). There are two structures of GDPbound WT Gai1 monomer have also been reported, one is in a Mg 2+ -free state (Mixon et al., 1995) and the other is in a Mg 2+ -bound state (Coleman and Sprang, 1998) . We did not choose them as representative of the inactive structure of (D) The conformational differences between the switch regions in our structure (active) and that in the structure of GDP-bound Gai1(WT) (inactive).
(E) Alignment of our structure with the crystal structure of GTPgS-bound Gas(WT) (colored cyan, PDB: 1AZT). The switch regions of GTPgS-bound Gas(WT) are colored slate.
(F) The local structure of the nucleotide binding pocket of GTPgS-bound Gas(WT). All structural figures were made using PyMOL. See also Figures S2, S3, and Table S1 .
Gai1 because switch II and III in both the two structures are disordered and invisible; in addition, without the inhibition by Gbg subunits, GDP-bound Gas has considerable activity to activate adenylyl cyclase (Sunahara et al., 1997a) , indicating that GDP-bound Ga proteins alone are not in a fully inactive state. We next aligned our structure with a structure of GTPgSbound Gas (PDB: 1AZT), which was the first crystal structure of Gas solved, representing the active conformation of Gas (Sunahara et al., 1997b) . Surprisingly, the conformation of the switch regions in our structure is very similar to that in the structure of GTPgS-bound Gas ( Figure 2E ). The local conformation of the nucleotide binding pocket in our structure is also nearly the same as that in the GTPgS-bound structure ( Figure 2F ), suggesting that our GDP-bound structure of Gas(R201C/C237S) is in an active conformation.
The above analysis suggests that despite being bound to GDP, Gas(R201C/C237S) is in an active conformation. This finding may provide an explanation for the GDP dissociation rates of the R201C mutant at different Mg 2+ concentrations. In the presence of millimolar free Mg
2+
, GDP-bound Gas(R201C) prefers to adopt an active-like conformation, in which GDP is not easily released, so its GDP dissociation rate is much slower than that of WT Gas ( Figure 1C ); Mg 2+ stabilizes the active-like conformation through forming water-mediated hydrogen bonds with D223 and through coordinating with GDP to inhibit GDP release ( Figure 2B ). Once the free Mg 2+ concentration is lowered to micromolar range, GDP-bound Gas(R201C) can no longer maintain an active-like conformation. Based on the crystal structure of GDP-bound WT Gai1 (PDB: 1GP2), in the inactive conformation, the side chains of R201 and E50 form two hydrogen bonds to block GDP dissociation ( Figure 4C ); the R201C mutation facilitates GDP dissociation through disrupting the two hydrogen bonds at low Mg 2+ concentrations. It should be noted that the active conformation of the GDPbound Gas(R201C) is not a perfect mimic of the canonical active state, as it lacks several stabilizing interactions observed in GNP-bound Gas. In the latter, Mg 2+ interacts with D223 directly and forms a hydrogen bond with the side chain of T204 in switch I; the g-phosphate accepts hydrogen bonds from the main chain amide of G226 and the side chain of K53 to further stabilize the active conformation ( Figure 2F ).
GDP-Bound Gas(R201C) Effectively Binds to and Activates Adenylyl Cyclase
We next determined whether the GDP-bound Gas(R201C) observed crystallographically can activate its downstream effector, adenylyl cyclase. The switch II region of Gas is responsible for binding and activation of adenylyl cyclase. This same switch region is also involved in binding to Gbg subunits. In its inactive conformation, switch II prefers to bind to Gbg subunits, while in its active conformation, it prefers adenylyl cyclase. The ability of Gas to bind adenylyl cyclase is strongly influenced by the presence of Gbg subunits, so we included Gbg subunits in our analysis. Five isoforms of Gb and 12 isoforms of Gg in mammalian cells have been identified (Khan et al., 2013) , among them, the Gb1/Gg2 complex was reported to be one of the combinations that interact with Gas (Rasmussen et al., 2011).
Prenylation of Gg at residue C68 is responsible for attaching the Gbg complex to cell membranes (Muntz et al., 1992) . The mutation C68S creates a soluble form of the Gb1/Gg2 complex. Nine isoforms of mammalian membrane-bound adenylyl cyclase have been identified; each isoform consists of two transmembrane domains and a cytoplasmic domain (Hanoune and Defer, 2001 ). The cytoplasmic domain, which can be further divided into C1 and C2 domains, is the catalytic domain that can be activated by Gas. The full-length as well as the cytoplasmic domain are difficult to overexpress in E. coli, but the C1 domain of adenylyl cyclase V (VC1) and C2 domain of adenylyl cyclase II (IIC2) can be overexpressed in E. coli. VC1 and IIC2 form a complex in the presence of Forskolin (FSK), and this complex can be activated by Gas (Sunahara et al., 1997a) . We expressed and purified the recombinant human VC1 and IIC2, as well as the Gb1/Gg2(C68S) complex, to reconstitute Gas activity assays. We used gel filtration to evaluate the ability of Gas to bind to adenylyl cyclase (VC1/IIC2) in the presence of Gb1/Gg2(C68S) ( Figure 3A ). VC1/IIC2 and Gb1/Gg2(C68S) were injected separately as controls ( Figure 3A , top). After incubation with both VC1/IIC2 and Gb1/Gg2(C68S), WT Gas in the GDP-bound state selectively bound Gb1/Gg2(C68S) to form a ternary complex, while in the GNP-bound state, it mainly formed a complex with VC1/IIC2 ( Figure 3A , middle). In contrast, in the GDPbound state, though most Gas(R201C) associated with Gb1/ Gg2(C68S), a small fraction formed a complex with VC1/IIC2; in the GNP-bound state, Gas(R201C) exclusively bound to VC1/IIC2 ( Figure 3A, bottom) . The results of WT Gas are consistent with the current view that Ga in GDP-bound state forms a ternary complex with Gbg subunits, while in GTP-bound state, Ga binds to its effectors (Sprang, 2016) . However, the results of Gas(R201C) indicate that the R201C mutation enables GDPbound Gas to bind to adenylyl cyclase even in the presence of Gb1/Gg2(C68S), although the binding is weaker than that between GNP-bound Gas and adenylyl cyclase.
Next, we evaluated the ability of Gas to activate adenylyl cyclase. Production of cAMP catalyzed by adenylyl cyclase was measured by a time-resolved fluorescence resonance energy transfer (TR-FRET) assay. In the absence of Gbg subunits, WT Gas and the R201C mutant in the GDP-bound state showed similar activity ( Figure 3B) ; but in the presence of Gbg subunits, WT Gas was significantly inhibited, while the R201C mutant was only modestly inhibited ( Figure 3B ). After incubation with GNP, both WT Gas and the R201C mutant showed higher activities, and the activities also decreased in the presence of Gbg subunits ( Figure 3C ), but again, the R201C mutant showed a higher activity. These results demonstrate a strong inhibitory effect of Gbg subunits on the adenylyl cyclase-activating activity of GDPbound Gas and prove that GDP-bound Gas(R201C) can partly bind to and activate adenylyl cyclase even in the presence of Gbg subunits.
An Intramolecular Hydrogen Bond Network Stabilizes the Active Conformation of Gas How does the R201C mutation result in activation of GDP-bound Gas even in the presence of Gbg subunits? A nuclear magnetic resonance (NMR) study of Gai1 indicates that GDP-bound Ga subunits dynamically exist in two conformational states: a ground state that is preferred by G protein-coupled receptors (GPCRs) and an excited state that is similar to the GTP-bound state (Goricanec et al., 2016) . The R201C mutation may shift the equilibrium toward the excited state. After analyzing the structures of GDP-bound Gas(R201C/C237S) and GTPgSbound WT Gas (PDB: 1AZT), we identified an intramolecular hydrogen bond network (H-bond network) between the P loop, switch III, and switch II in both structures. Residue E50 in the P loop accepts hydrogen bonds from residues R258 and R265 in switch III. Residues E259, D260, T263, and E268 in switch III form hydrogen bonds with residues R228 and R231 in switch II ( Figures 4A, 4B , S3B, and S3C). We also built a model of the inactive state of Gas based on the structure of GDP-bound Gai1 (PDB: 1GP2), using SWISS-MODEL (Biasini et al., 2014) . In this model, residue R201 in switch I donates two hydrogen bonds to E50 in the P loop; switch III and switch II are far from each other ( Figure 4C ).
Based on the analysis, we developed a model to explain the effect of the R201C mutation on the functional state of Gas (Figure 4D ). In the GDP-bound state, ammonium h1 and h2 of R201 tend to make an end-on salt-bridge with E50 to preclude the interactions between E50 and R258, R265 ( Figure 4D, bottom) . The R201C mutation results in the loss of ammonium h1 and h2 of R201 thus freeing E50 to interact with R258 and R265, bringing switch III close to switch II to facilitate their interactions ( Figure 4D, top) . This H-bond network stabilizes Gas in an active-like conformation, decreasing its affinity for Gbg subunits to facilitate its interaction with adenylyl cyclase. GTP binding (A) GDP-bound Gas(R201C) can partly bind to adenylyl cyclase even in the presence of Gb1/ g2(C68S). WT Gas or the R201C mutant was first incubated with GDP or GNP and then incubated with Gb1/g2(C68S), adenylyl cyclase (consisting of VC1 and IIC2), and Forskolin (FSK). The mixture was then separated by gel filtration and analyzed by SDS-PAGE. The PAGE gels surrounded by red outlines and that surrounded by blue outlines correspond to the gel filtration chromatograms with red and blue colors, respectively. The single arrow (Y) and double arrow (YY) indicate the peak position of the Gas/VC1/IIC2 complex and that of the Gas/Gb1/g2(C68S) complex, respectively. (B and C) Activation of adenylyl cyclase by Gas in the absence or presence of Gb1/g2(C68S) complex. GDP-bound Gas was first incubated with GDP (B) or a mixture of GDP and GNP (C) and then mixed with Gb1/g2(C68S) complex (or buffer), adenylyl cyclase (VC1/IIC2), FSK. After adding ATP, the reaction was carried out at 30 C for 10 min. Production of cAMP was evaluated by the LANCE Ultra cAMP kit. The data represent the mean ± SE of six independent measurements. may attract R201 to disrupt its interaction with E50, playing a similar role as the R201C mutation ( Figure 4D , top). Most residues in this network are highly conserved across the a-subunits of human heterotrimeric G proteins ( Figure S4 ) (Flock et al., 2015 ).
An Arginine Mimic Lacking N(ε) at Position 201 Corrects GDP-Misactivation of Gas(R201C)
The above model indicates the importance of the interactions between E50 and ammonium h1 and h2 of R201 in maintaining GDP-bound Gas in an inactive state. To test this model, we sought to replace the side chain of R201C with a close mimic of native arginine that contains N(h1) and N(h2) but lacking N(ε) that is not predicted to be involved in the H-bond network. The cysteine at position 201 offers an opportunity for site-specific alkylation to introduce such an arginine analog. Upon reaction with cysteine residues, acrylamidine creates an arginine mimetic with an amidine functionality lacking N(ε) ( Figure 5A ) (Le et al., 2013) . We first tested the reactivity of acrylamidine toward WT Gas. In the construct of WT Gas we used in this study, there are 7 native cysteine residues, but the liquid chromatography and mass spectrometry (LC/MS) analysis indicated that only one of them could be modified by acrylamidine, and when C237 was mutated to serine (C237S), no adduct peak could be detected ( Figure 5B ). This suggests that C237 is the only cysteine residue that can be modified by acrylamidine in WT Gas. Next, we tested the ability of acrylamidine to modify Gas(R201C), and two adduct peaks were detected: one was Gas(R201C) modified by one molecule of acrylamidine, while the other was modified by two molecules of acrylamidine, indicating that C201 was also modified in addition to C237. In the R201C/C237S mutant, C201 is the only residue that can be modified by acrylamidine as only one adduct peak was detected ( Figure 5B) .
We evaluated the effect of modifying C201 with acrylamidine on the adenylyl cyclase-activating activity of GDP-bound Gas(R201C/C237S). In the presence of GDP and Gb1/ Gg2(C68S), the unmodified Gas(R201C/C237S) showed significantly higher activity than Gas(C237S) ( Figure 5C ), consistent with our finding that Gas(R201C) has a higher activity than WT Gas ( Figure 3B ). After Gas(R201C/C237S) was modified by acrylamidine (free acrylamidine was removed by gel filtration), its ability to activate adenylyl cyclase was lowered to the same level as that of Gas(C237S) ( Figure 5C ). We conclude that site-specific modification of C201 with acrylamidine can effectively restore the canonical role of GDP to Gas disrupted by the R201C mutation, supporting the role of N(h1) and N(h2) in restraining the GDP-bound form in a state that does not activate adenylyl cyclase in the presence of Gbg subunits. We also demonstrated that this modification can partly restore the GTPase activity of Gas(R201C/C237S). The k cat of Gas(C237S) is 1.539 ± 0.153 min À1 (measured at 0 C), slightly higher than that of WT Gas ( Figure 5D ). The unmodified R201C/C237S mutant showed a slow k cat (0.022 ± 0.002 min
À1
) even at 20 C, similar to that of Gas(R201C). Following acrylamidine modification of the (A and B) In the crystal structure of GDP-bound Gas(R201C/C237S) (A) and that of GTPgS-bound Gas(WT) (B) , E50 in the P loop interacts with R258 and R265 in switch III through hydrogen bonding, while E259, D260, T263, and E268 in switch III accept hydrogen bonds from R228 and R231 in switch II. The hydrogen bonds are showed as yellow dash lines. (C) A model of GDP-bound Gas(WT) in an inactive conformation based on the crystal structure of GDP-bound Gai1(WT) (PDB: 1GP2) was built by SWISS-MODEL (Biasini et al., 2014) . In this model, R201 in switch I donates two hydrogen bonds to E50 in the P loop, blocking the interaction between E50 and R258, R265. R201C/C237S mutant its k cat increased to 0.471 ± 0.043 min À1 (measured at 0 C), $30% of that of Gas(C237S).
Mutations of the H-Bond Network
Destabilize the Active State Loss-of-function mutations in the H-bond network of Gas have been identified in PHP-Ia and characterized by loss of the ability to stimulate Gas (Lemos and Thakker, 2015) . Two biochemical mechanisms have been characterized to explain their inactivating effects: (1) mutations such as R231H (Iiri et al., 1997) and R265H (Leyme et al., 2014) , impair Gas activation through destabilization of GTP binding, and (2) a second class of mutations, represented by R258A, turn off GTP-bound Gas very quickly by increasing the intrinsic GTP hydrolysis rate of Gas (Warner and Weinstein, 1999; Warner et al., 1998) .
The finding that the gain-of-function mutation R201C stabilizes the H-bond network to activate GDP-bound Gas lead us to investigate whether a third potential mechanism for the loss-of-function mutations could be due to destabilization of the active conformation in GTP-bound Gas causing a decrease in effector stimulation. To test this mechanism, we generated three Gas mutants: R265H, R258A, and R228C, the first two that have been characterized previously while R228C is a novel mutation recently identified in PHP-Ia (Tam et al., 2014) . Residue R228 mediates the switch III-switch II interactions together with residue R231 (Figure 4) .
We expressed and purified these mutants and first tested their properties with respect to mechanisms (1) and (2). The R228C, R258A, and R265H mutants all exhibited increased steady-state GTP hydrolysis rates, which were 1.5-, 4-, and 7.5-fold that of WT Gas, respectively ( Figure 6A ). Because the GTP hydrolysis cycle consists of a slower nucleotide exchange step (replacement of GDP by GTP) Ross, 1985, 1986; Higashijima et al., 1987a) followed by a GTP hydrolysis step, we hypothesized that mutations R228C, R258A, and R265H accelerate nucleotide exchange. WT Gas and the mutants in a GDP-bound state were incubated with [
35 S]GTPgS and excess GTPgS to measure GTPgS binding. All three Gas mutants increased the apparent rate of GTPgS binding to Gas (k app ) ( Figures 6B and  6F ). Among them, R265H showed the fastest binding rate, followed by R258A and R228C, consistent with their steady-state GTP hydrolysis rates. Rates of GTP binding to G proteins are thought to be limited by GDP dissociation rates (Gilman, 1987) . We confirmed that mutations R228C and R258A facilitate GDP dissociation ( Figure S5 ). The rate of GDP dissociation from the R265H mutant was too fast to be quantified using the [ 3 H] GDP assay.
We next tested whether GTPase activity is elevated in the mutants (mechanism 2) ( Figures 6C and 6F) . The GTP hydrolysis rate (k cat ) of R258A is 8.090 ± 1.353 min À1 , consistent with the reported data (Warner and Weinstein, 1999) . The R265H mutant also showed a higher GTPase activity, with its k cat twice that of WT Gas. The R228C mutant showed a similar GTPase activity to that of the WT. These results indicate that mechanism (2) is involved in the inactivating effects of the R258A and R265H mutations, but cannot explain how R228C decreases Gas activity.
As a result of the ability of R228C Gas to bind and hydrolyze GTP at close to WT efficiency, we asked if destabilization of the active state might be responsible for its loss-of-function behavior. We compared the adenylyl cyclase-activating activities of these mutants with that of WT Gas in the presence of Gb1/Gg2(C68S). When 300 mM GDP was present, the activities of all three mutants were undetectable using the TR-FRET assay even at a concentration of 2 mM, while WT Gas showed much higher activity at this concentration ( Figure 6D ). When GNP was added, the activities of these mutants were increased significantly, but were still lower than that of WT Gas ( Figures 6E and  6F ). Among these, R228C severely decreased the activity of Gas, providing a new mechanism to explain the loss-of-function behavior in which the stimulation of effector is diminished despite its retention of near WT levels of GTP binding and GTPase activity.
DISCUSSION
GPCRs and G proteins comprise the largest family of signal transducing proteins in the human genome. G proteins are the targets of somatic and inherited mutations as well as cell penetrating toxins. The most frequent cancer-causing mutation among all heterotrimeric G proteins (and GPCRs) is position R201 in Gas, leading to its constitutive activation, driving cAMP pathways (O'Hayre et al., 2013) . This same arginine residue is ADP-ribosylated by the cholera toxin causing constitutive activation, elevation of cAMP levels, and activation of the cystic fibrosis transmembrane conductance regulator (CFTR) (De Haan and Hirst, 2004) . The guanidine moiety of R201 is critical for GTP hydrolysis and its disruption by mutation (R201C/H) or ADP-ribosylation leads to a decrease in GTPase hydrolysis rate (Landis et al., 1989) .
Mutations in oncogenes are often not confined to a single dominant hot-spot (e.g., RAS mutations at G12, Q61 both disrupt GTPase activity and are found frequently). Mutations that hyper-activate biochemical functions such as kinase activities in oncogenes such BRAF in contrast are often dominated by a single hotspot (V600E) due to the difficulty of enhancing in comparison to compromising catalytic activity. (B) Analysis of the modification of Gas using liquid chromatography and mass spectrometry (LC/MS). Before analysis, 6 mM Gas was incubated with 500 mM acrylamidine at room temperature for 2 hr. According to the molecular mass spectra, WT Gas was completely modified by one molecule of Acr, and mutating C237 to serine blocked this modification; introduction of the R201C mutation enabled Gas to be modified by one additional Acr. (C) Modification of C201 by acrylamidine decreased the adenylyl cyclase-activating activity of the R201C/C237S mutant. The adenylyl cyclase activity was measured in the presence of GDP and Gb1/g2(C68S). The data represent the mean ± SE of three independent measurements. (D) Modification of C201 by acrylamidine increased the single turnover GTPase activity of the R201C/C237S mutant to a level close to that of the C237S mutant. The data represent the mean ± SD of at least three independent measurements. Our biochemical and structural data reveal that the R201C Gas mutant not only exhibits decreased GTPase activity but is also capable of activating adenylyl cyclase when bound to GDP even in the presence of Gbg subunits. This new activation mechanism may explain the highly focused Gas mutations in cancer. Although not a subject of our studies, several studies of the activation of R201 by ADP-ribosylation, suggest that mechanisms in addition to the loss of GTPase activity may also be involved. In particular, ADP-ribosylation of R201 was shown to disrupt Gas binding to Gbg (Kahn and Gilman, 1984) . Such a result cannot be explained by the GTPase-inhibiting effect of ADP-ribosylation, but can be explained by our data.
One potential confounding aspect of the R201C mutant is the presence of two effects: (1) a decrease in GTPase rate leading to increased stability of the activator-GTP, and (2) the ability to be active in the GDP state. To support the notion that pathophysiology can be driven by a non-canonical nucleotide state, we would need to identify a disease-causing mutation in which the only effect is due to a non-canonical nucleotide effect. Therefore, we pursued the study of the mutations found in PHP-1a patients. The hypomorphic mutations of Gas that cause PHP-1a have been identified at multiple residues with no dominant hot-spots, consistent with the notion that many different residues can be targeted to disrupt adenylyl cyclase stimulation by Gas. Biochemical studies including those described here identified PHP-1a-causing Gas mutations with increased GTPase activity that explain their hypomorphic activity. We did not find support (although we did not search exhaustively) for one mechanism proposed in the literature, that of an inability to bind GTP (Leyme et al., 2014) . One of the hypomorphic mutations identified recently in patients and biochemically analyzed here, R228C (Tam et al., 2014) , could bind and hydrolyze GTP with nearly the same biochemical constants of WT Gas, prompting our search for a new mechanism explaining the loss of G protein function. Based on our finding that the R201C mutation could subvert the normal inability of GDP to activate adenylyl cyclase, we asked if R228C was compromised in its ability to activate adenylyl cyclase when bound to GTP analogs. Indeed, even with GNP bound to R228C, the protein showed significantly reduced ability to stimulate adenylyl cyclase, again demonstrating the ability of a disease mutation to alter the normal nucleotide control of a G protein, in this case with GTP. That disease-causing mutations in Gas can subvert the roles of both GDP and GTP provides new insights into the plasticity of these central switches in pathophysiology. Cyclase-Activating Activity of Gas (A) The steady-state GTP hydrolysis rates of WT Gas and the R228C, R258A, and R265H mutants were determined at 37 C. The data represent the mean ± SD of three independent measurements. (B) The rates of GTPgS binding to WT Gas and the R228C, R258A, and R265H mutants were determined by mixing GDP-bound Gas with a mixture of [ 35 S]GTPgS and GTPgS in a buffer containing 2.5 mM MgCl 2 and 1 mM EDTA. The data represent the mean ± SD of two independent measurements. (C) The single turnover GTPase activities of WT Gas and the R228C, R258A, and R265H mutants were determined at 0 C. The data represent the mean ± SD of four (WT) or three (R228C, R258A, and R265H) independent measurements. The data of WT Gas used here was also used in Figure 1A .
(D and E) Activation of adenylyl cyclase by Gas in the presence of Gb1/g2(C68S). GDP-bound Gas was first incubated with GDP (D) or a mixture of GDP and GNP (E) and then mixed with Gb1/g2(C68S), adenylyl cyclase (VC1/IIC2), and FSK. The reaction was initiated by adding ATP. The data represent the mean ± SE of three (D) or nine (E) independent measurements. (F) Visualization of the effects of mutations R228C, R258A, and R265H on the apparent GTPgS binding rate (k app ), intrinsic GTPase activity (k cat ), and the adenylyl cyclase-activating activity (EC 50 ) of Gas. See also Figures S4 and S5.
Our finding that the R201C mutant is not in a persistent GTP state sheds light on the future development of inhibitors of this oncogenic mutant. The best characterized small molecule inhibitor of heterotrimeric G proteins is the natural product YM-254890 that binds to GDP-bound Gaq to inhibit Gaq activation (Nishimura et al., 2010) . Our results suggest that YM-254890 analogs that bind to Gas rather than Gaq would be capable of treating patients with R201C mutation. Prior to our work, such a therapeutic strategy would not seem viable because the prior literature suggests only the GTP state predominates. Similar logic has been applied to find small molecule inhibitors of K-Ras (G12C) that bind to the GDP state of the oncogenic mutant in cells (Ostrem et al., 2013) , when prior work had suggested oncogenic K-Ras mutants are uniformly in a persistent GTP state. These two examples of gain-of-function mutations in GTPases suggest that the widespread view that such proteins are ''locked'' in the GTP state, which is widely appreciated to be recalcitrant to high-affinity small-molecule binding, is not correct, providing an opportunity for drug discovery against the GDP state.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell Culture WT Gas, all the mutants of Gas, the C1 domain (residues 442-658, VC1) of human ADCY5 (adenylyl cyclase V) and the C2 domain (residues 871-1082, IIC2) of human ADCY2 (adenylyl cyclase II) were overexpressed in Escherichia coli BL21(DE3) cultured in Terrific Broth (TB) Medium. Human GNB1 (Gb1) and GNG2 (Gg2) were co-expressed in Sf9 insect cells cultured in Sf-900 III SFM medium at 28 C.
METHOD DETAILS Protein expression and purification
The gene of residues 7-380 of the short isoform of human Gas (GNAS, accession number in PubMed: NP_536351) with a stop codon at its end was cloned into the NdeI/XhoI site of a modified pET15b vector, in which a Drice cleavage site (AspGluValAspYAla) was inserted between the thrombin cleavage site and the NdeI site. The plasmid was transformed into Escherichia coli BL21(DE3). The transformed cells were grown in TB medium supplemented with 50 mg/mL carbenicillin at 37 C until OD600 reached 0.5, and then cooled to 22 C followed by addition of 40 mM b-D-thiogalactopyranoside (IPTG). After overnight incubation, the cells were harvested by centrifugation, resuspended in lysis buffer (150 mM NaCl, 25 mM Tris 8.0, 1 mM MgCl 2 ), and then lysed by a microfluidizer. The cell lysate was centrifuged at 14000 g for 1 hour at 4 C. The supernatant was incubated with TALON Resin (Clontech Laboratories) at 4 C for 1 hour, then the resin was washed by 500 mM NaCl, 25 mM Tris 8.0, 1 mM MgCl 2 and 5 mM imidazole 8.0. Gas was eluted by 25 mM Tris 8.0, 1 mM MgCl 2 , 250 mM imidazole 8.0, 10% glycerol and 0.1 mM GDP. After adding 5 mM Dithiothreitol (DTT), the eluate was incubated with Drice at 4 C overnight to remove the hexahistidine tag and loaded into a Source-15Q column (GE Healthcare). Gas was eluted by a linear gradient from 100% buffer A (25 mM Tris 8.0, 1 mM MgCl 2 ) to 40% Buffer B (25 mM Tris 8.0, 1 M NaCl, 1 mM MgCl 2 ). The peak fractions were pooled, supplemented with 5 mM DTT and 0.1 mM GDP, and then concentrated and purified by gel filtration (Superdex 200 increase, 10/30, GE Healthcare) with buffer C (150 mM NaCl, 20 mM HEPES 8.0, 5 mM MgCl 2 and 1 mM EDTA-Na 8.0). The peak fractions were pooled and concentrated for biochemical assay. All mutants of Gas were expressed and purified with the same protocol. The C2 domain of human ADCY2 (residues 871-1082, IIC2) was also expressed and purified with the same protocol, except that no GDP was added during purification.
Residues D628 and S645 in the C1 domain (residues 443-659) of mouse ADCY5 (adenylyl cyclase V) were mutated to glutamic acid and arginine, respectively, resulting a sequence that is the same as the C1 domain of human ADCY5 (residues 442-658). The gene of this sequence was cloned into the NdeI/XhoI site of a pET29b vector. The transformed Escherichia coli BL21(DE3) cells were cultured in TB medium supplemented with 50 mg/mL kanamycin at 37 C until OD600 reached 0.5, and then cooled to 22 C followed by addition of 40 mM IPTG. After incubation at 22 C for 4-5 hours, the cells were harvested, lysed. After centrifugation, the supernatant was purified by TALON Resin with the same protocol described above. The eluate was mixed with 5 mM DTT and further purified by gel filtration (Superdex 200 increase, 10/30, GE Healthcare) with buffer C (150 mM NaCl, 20 mM HEPES 8.0, 5 mM MgCl 2 and 1 mM EDTA-Na 8.0).
Human Gb1 with a hexahistidine tag at its N terminus and human Gg2(C68S) were cloned into pFastBac Dual expression vector (Invitrogen). The plasmid was transformed into DH10Bac competent cells to generate bacmid DNA, which was then used to generate baculoviruses in Sf9 insect cells (Invitrogen). Sf9 cells grown in Sf-900 III SFM medium with a density of 1.8x10 6 cells/mL was infected by the baculoviruses. Forty-eight hours later, the cells were harvested by centrifugation, and resuspended in lysis buffer (150 mM NaCl, 25 mM Tris 8.0, 1 mM MgCl 2 ) supplemented with cOmplete Protease Inhibitor Cocktail (Sigma-aldrich). The cells were disrupted by a microfluidizer. After centrifugation, the supernatant was purified by TALON Resin and gel filtration (Superdex 200 increase, 10/30, GE Healthcare) with the same buffers used for Gas purification.
HPLC analysis
Wide type Gas or the R201C mutant purified by gel filtration was concentrated to 11.5 mg/mL (about 0.25 mM). EDTA-Na 8.0 was added to a final concentration of 10 mM. The protein was then denatured by heating at 98 C for 5 minutes. The bound nucleotides were released from the proteins and then analyzed by HPLC using a method described previously (Hertz et al., 2013) . After centrifuging at 20,000 g for 10 minutes at room temperature, 20 mL of the supernatant was injected into a C-18 column (Agilent ZORBAX 300SB-C18) in a HPLC system (Waters) and eluted by a linear gradient from 100% buffer A (5 mM tetrabutylammonium bromide, 25 mM KH 2 PO4 pH 6.5, 5% acetonitrile) to 65% buffer B (5 mM tetrabutylammonium bromide, 25 mM KH 2 PO4 pH 6.5, 60% acetonitrile) over 40 minutes using a flow rate of 1 mL/min. As standards, GMP, GDP and GTP in the gel filtration buffer were also treated with EDTA and heat before injection.
Calculation of the free Mg 2+ concentration
The concentrations of free Mg 2+ were calculated following a method described previously (Higashijima et al., 1987c) . In our in vitro assays, the total Mg 2+ concentration is presumed to be the sum of the concentrations of free Mg
2+
, Mg 2+ in complex with EDTA, GDP, GTP (or GNP, GTPgS), and Mg 2+ bound to Gas. Because the concentration of Gas used in each assay was much lower than the total Mg 2+ concentration, the contribution of Gas to the free Mg 2+ concentration was neglected in the calculation. , the Kd is 1 mM at pH 7.6 (Higashijima et al., 1987c) , and we adopted this number in our calculation. The Kd value for GDP-Mg 2+ binding or for GTP-Mg 2+ binding has not been reported, so instead, we used the Kd values for ADP-Mg 2+ binding (670 ± 50 mM) and for ATP-Mg 2+ binding (35 ± 3 mM) reported previously (Gout et al., 2014) Steady-state GTPase assay WT Gas and its mutants purified by gel filtration were concentrated to 8.5 mg/mL and then adjusted to 3 mM (WT) or 0.6 mM (R228C, R258A, R265H) in 20 mM HEPES 7.5, 150 mM NaCl, 1 mM EDTA-Na 8.0. The proteins were 1:1 (v:v) diluted with the reaction buffer (20 mM HEPES 7.5, 150 mM NaCl, 20 mM MgCl 2 and 1 mM GTP), and incubated at 37 C. After 20, 30, 48, 70 or 100 minutes, 100 mL of the sample was removed to measure the inorganic phosphate (Pi) concentration by PiColorLock Phosphate Detection kit (Innova Biosciences). A standard curve was made using the 0.1 mM Pi stock in the kit.
Tryptophan fluorescence
Gas at a concentration of 8.5 mg/mL in 20 mM HEPES 8.0, 150 mM NaCl were adjusted to 10 mM in the dilution buffer (20 mM HEPES 7.5, 150 mM NaCl, 1 mM EDTA-Na 8.0, 2 mM DTT and 50 uM GDP), transferred to a costar 96-well black microplate with a volume of 50 mL/well. After adding 50 mL of GTP or GNP stock (1 mM GTP or GNP in the dilution buffer plus 0.2 mM MgCl 2 ) to each well, the plate was immediately read by a SpectraMax M5 plate reader (Molecular Devices) at room temperature using an excitation wavelength of 290 nm and an emission wavelength of 340 nm.
Gel filtration GDP-bound WT Gas or the R201C mutant (30 mM) was incubated with 1 mM GDP, 45 mM VC1, 60 mM IIC2, 39 mM Gb1/g2(C68S) complex, 100 mM Forskolin (FSK), 2 mM DTT on ice for 2 hours. Then 200 mL of the mixture was separated by gel filtration (Superdex 200 increase, 10/30, GE Healthcare) with buffer D (150 mM NaCl, 20 mM HEPES 8.0, 5 mM MgCl 2 , 1 mM EDTA-Na 8.0, 2 mM DTT and 25 mM FSK). The fractions were analyzed by SDS-PAGE and stained by Coomassie blue. GNP-bound Gas was incubated with the same components except that GDP was replaced by GNP. To generate GNP-bound Gas(WT) or Gas(R201C), the protein purified by Source-15Q column was concentrated to about 12 mg/mL and then diluted to about 1 mg/mL with a buffer containing 20 mM HEPES 8.0, 150 mM NaCl, 1 mM EDTA, 5 mM DTT and 0.5 mM GNP. After incubation at room temperature for 1 hour, 20 mM MgCl 2 was added to stabilize the protein. The GNP-bound protein was purified by gel filtration (Superdex 200 increase, 10/30, GE Healthcare) with buffer C (150 mM NaCl, 20 mM HEPES 8.0, 5 mM MgCl 2 and 1 mM EDTA-Na 8.0).
Adenylyl cyclase activity assay WT Gas and the mutants at a concentration of 8.5 mg/mL (about 190 mM) in 20 mM HEPES 8.0, 150 mM NaCl, 5 mM MgCl 2 , 1 mM EDTA-Na 8.0 were diluted to a series concentrations (8 mM, 4 mM, 2 mM, 1 mM, 0.5 mM, 0.25 mM, 125 nM, 62.5 nM, 31 nM, 15.6 nM) in buffer E (1x PBS 7.4, 0.1% BSA, 1 mM EDTA-Na 8.0, 2 mM DTT) plus 0.2 mM GDP. 5 mL of each sample was then mixed with 5 mL of GDP stock (buffer E plus 1 mM GDP) or GNP stock (buffer E plus 1 mM GNP) in a non-skirted 96-well PCR plate (USA Scientific). After incubation at room temperature for 1.5 hour to allow nucleotide exchange, 2 mL of MgCl 2 stock (20 mM MgCl 2 , 1x PBS 7.4, 0.1% BSA) was added, followed by addition of 4 mL of AC stock (10 mM VC1, 5 nM IIC2, 150 mM FSK, 1x PBS 7.4, 0.1% BSA) or AC/Gbg stock (AC stock plus 20 mM Gb1/g2(C68S)). After incubation at room temperature for 1 hour, the samples were placed on ice for 5 minutes. cAMP production was initiated by addition of 4 mL of ATP stock (1 mM ATP, 1x PBS 7.4, 0.1% BSA). The reaction was carried out at 30 C for 10 minutes in a PCR machine, and stopped by heating at 95 C for 3 minutes. The cAMP concentrations were measured by the LANCE Ultra cAMP kit (PerkinElmer). A cAMP standard curve was generated in the same plate using the 50 mM cAMP standard in the kit. Before the measurement, the samples were diluted by stimulation buffer (1x PBS 7.4, 0.1% BSA) to 1/60, 1/120, 1/240 or 1/480 to make sure the cAMP concentrations were in the dynamic range of the cAMP standard curve. 20 mL of each diluted sample was mixed with 10 mL of 4X Eu-cAMP tracer and 10 mL of 4X ULight-anti-cAMP in a white, opaque Optiplate-384 microplate, incubated for 1 hour at room temperature, and the time-resolved fluorescence resonance energy transfer (TR-FRET) signals were read on a Spark 20M plate reader.
The cAMP standard curve was fitted by the software GraphPad Prism using the following equation in which ''Y'' is the TR-FRET signal and ''X'' is the log of cAMP standard concentration (M): in which ''Y'' is the cAMP production value, ''X'' is the log of Gas concentration (M).
GDP dissociation assay
Gas at a concentration of 8.5 mg/mL (about 190 mM) in 20 mM HEPES 8.0, 150 mM NaCl, 5 mM MgCl 2 , 1 mM EDTA-Na 8.0 was diluted to 400 nM in an EDTA buffer (20 mM HEPES 7.5, 150 mM NaCl, 1 mM EDTA-Na 8.0, 2 mM DTT). [
3 H]GDP (1 mCi/mL, 24 mM) was added to a final concentration of 1.2 mM. After incubation at 20 C for 3 hours, the same volume of assay buffer (1 mM, 5 mM or 10 mM MgCl 2 in the EDTA buffer plus 1 mM GDP, or 5 mM MgCl 2 and 2 mM Gb/g(C68S) in EDTA buffer plus 1 mM GDP) was added to initiate [ 3 H]GDP dissociation. At various points, 20 mL of the sample was removed and mixed with 380 mL of ice-cold wash buffer (20 mM HEPES 7.5, 150 mM NaCl, 20 mM MgCl 2 ). The mixture was immediately filtered through a mixed cellulose membrane (25 mm, 0.22 mm) held by a microanalysis filter holder (EMD Millipore). The membrane was washed by ice-cold wash buffer (500 mL x 3), put in a 6-mL plastic vial and air-dried (room temperature 1.5 h). 5 mL of CytoScint-ES Liquid Scintillation Cocktail (MP Biomedicals) was added to each vial. After incubation overnight at room temperature, the vial was used for liquid scintillation counting with a LS 6500 Multi-Purpose Scintillation Counter (Beckman Coulter). The GDP dissociation curves were fitted by the software GraphPad Prism using the following equation to calculate the dissociation rates (k off ):
in which ''Y'' is the radioactivity (Counts per minute) of the sample at time ''X'' (minutes), and Y0 is the calculated radioactivity of the sample at the time point 0.
GTPgS binding assay
Gas at a concentration of 8.5 mg/mL (about 190 mM) in 20 mM HEPES 8.0, 150 mM NaCl, 5 mM MgCl 2 , 1 mM EDTA-Na 8.0 was diluted to 10 mM with dilution buffer (20 mM HEPES 7.5, 150 mM NaCl, 2.5 mM MgCl 2 , 1 mM EDTA-Na 8.0, 2 mM DTT). GTPgS binding was initiated by diluting the sample to 2 mM with the reaction buffer (50 nM [ 35 S]GTPgS and 100 mM GTPgS in dilution buffer) at room temperature. At various time points, 10 mL of the sample was removed and mixed with 390 mL of ice-cold wash buffer (20 mM HEPES 7.5, 150 mM NaCl, 20 mM MgCl 2 ). The mixture was filtered through a mixed cellulose membrane (25 mm, 0.22 mm). The membrane was washed by ice-cold wash buffer (500 mL x 3), put in a 6-mL plastic vial and air-dried (room temperature 1.5 h). 5 mL of CytoScint-ES Liquid Scintillation Cocktail (MP Biomedicals) was added to each vial. After incubation overnight at room temperature, the vial was used for liquid scintillation counting with a LS 6500 Multi-Purpose Scintillation Counter (Beckman Coulter).
A standard curve was generated using [ Single turnover GTPase assay Gas (WT, C237S, R201C/C237S-acrylamidine, R228C, R258A, R265H) at a concentration of 8.5 mg/mL (about 190 mM) in 20 mM HEPES 8.0, 150 mM NaCl was diluted to 1 mM in EDTA buffer (20 mM HEPES 7.5, 150 mM NaCl, 5 mM EDTA-Na 8.0, 2 mM DTT). After incubation with 10 nM [g-32 P]GTP (6476 Ci/mmol) on ice for 1.5 hour, 4 mL of the sample was removed and mixed with 580 mL of ice-cold 5% activated charcoal in 20 mM H 3 PO 4 , pH 2.4 (time point 0), while 29 mL of the sample was mixed with 116 mL of reaction buffer (20 mM HEPES 7.5, 150 mM NaCl, 20 mM MgCl 2 , 0.25 mM GTP) on ice. At various time points, 20 mL of the sample was removed and mixed with 580 mL of ice-cold 5% (wt/vol) activated charcoal in 20 mM H 3 PO 4 , pH 2.4 to stop the reaction. The activated charcoal slurry was then centrifuged for 5 min at 20,000 3 g (4 C), and 500 mL of the supernatant was carefully removed and mixed with 4.5 mL of CytoScint-ES Liquid Scintillation Cocktail (MP Biomedicals) in a 6-mL vial. The vial was used for liquid scintillation counting with a LS 6500 Multi-Purpose Scintillation Counter (Beckman Coulter). For each sample, the background [ 32 P]Pi detected at time point 0 was subtracted from the data.
To measure the single turnover GTP hydrolysis rates of the R201C and R201C/C237S mutants, the proteins were diluted to 1 mM in a low Mg 2+ buffer (20 mM HEPES 7.5, 150 mM NaCl, 1 mM EDTA-Na 8.0, 0.1 mM MgCl 2 , 2 mM DTT) and incubated with 10 nM [g-32 P] GTP (6476 Ci/mmol) at room temperature for 30 minutes before reaction buffer was added. The release of 32 PO 4 3-was measured at 20 C. The data was fitted by the software GraphPad Prism using the following equation to calculate the single turnover GTP hydrolysis rates (k cat ):
in which ''Y'' is the radioactivity of the [ 32 P]Pi released from the protein at time ''X'' (minutes).
[g-32 P]GTP binding assay The R201C mutant of Gas at a concentration of 8.5 mg/mL (about 190 uM) in 20 mM HEPES 8.0, 150 mM NaCl was diluted to 10 mM in dilution buffer (20 mM HEPES 7.5, 150 mM NaCl, 0.1 mM MgCl 2 , 1 mM EDTA-Na 8.0, 2 mM DTT). GTP binding was initiated by mixing 1 volume of the protein with 4 volumes of the reaction buffer (dilution buffer + 25 nM [g-32P]GTP + 500 mM GTP) at room temperature for 1 hour. 10 mL of the sample (1.238 mCi) was removed to measure the concentration of bound [g-32 P]GTP. This concentration was defined as the concentration at the zero time point. Then the sample was mixed with 1/10 volume of dilution buffer or MgCl 2 buffer (dilution buffer + 26.4 mM MgCl 2 ) or MgCl 2 /Gbg (dilution buffer + 26.4 mM MgCl 2 + 30 mM Gbg). After that, at each time point (5 min, 0.5 hour, 1.5 hours, 2.5 hours and 4 hours), 11 mL of the sample was removed and added into 390 mL of ice-cold wash buffer (20 mM HEPES 7.5, 150 mM NaCl, 20 mM MgCl 2 ). The mixture was filtered through mixed cellulose membranes (25 mm, 0.22 mm), washed by ice-cold wash buffer (500 mL x 3), and air-dried (room temperature 1.5 hours). The membrane was put in a 6-mL plastic vial in which 5 mL of CytoScint-ES Liquid Scintillation Cocktail (MP Biomedicals) was added. After incubation overnight at room temperature, the vial was used for liquid scintillation counting with a LS 6500 Multi-Purpose Scintillation Counter (Beckman Coulter). A standard curve was generated using [g-32 P]GTP.
Synthesis of acrylamidine
Acrylamidine was synthesized following the procedure in published literatures (Le et al., 2013; Zuev and Sheridan, 2004) . A mixture of 760 mg of NH 4 Cl in 10 mL anhydrous toluene was stirred at 0 C under argon atmosphere. Then 6.6 mL of trimethylaluminum solution in toluene (2.0 M) was added carefully. The reaction was stirred at room temperature (about 20 C) for 2 hours. After addition of 0.6 mL of acrylonitrile, the reaction was warmed to 80 C and stirred for 18 hours. The reaction was then transferred to a slurry of 5 g of silica gel in 15 mL of CHCl 3 , stirred on ice for 1 hour, and filtered and washed with methanol. The filtrate was evaporated to give the product as a white solid (509 mg, 80%). Our NMR data matched the reported data (Zuev and Sheridan, 2004) .
1 H NMR (400 MHz, DMSO-d6): d 9.22 (broad s, 1.5 H), 8.87 (broad s, 1.5 H), 6.57 (d, 1 H, J = 17.6 Hz), 6.35 (dd, 1 H, J = 17.6, 11.1 Hz), 6.12 (d, 1H, 11.1 Hz).
Crystallization Gas(R201C/C237S) that was purified by gel filtration was concentrated to 10 mg/mL and mixed with 1 mM GDP. For crystallization, 0.1 mL of the protein was mixed with 0.1 mL of the well buffer containing 0.1 M Tris 8.5, 25% PEG8000, 10 mM TCEP hydrochloride.
Crystals were grown at 20 C in a 96-well plate using the hanging-drop vapor-diffusion method, transferred to a cryoprotectant solution (the well buffer plus 25% glycerol), and flash-frozen in liquid nitrogen.
Data collection and structure determination
The dataset was collected at the Advanced Light Source beamline 8.2.2 with X-ray at a wavelength of 0.999907 Å . Then the dataset was indexed and integrated using iMosflm (Battye et al., 2011) , scaled with Scala (Evans, 2006) and solved by molecular replacement using Phaser (McCoy et al., 2007) in CCP4 software suite (Winn et al., 2011) . The crystal structure of GTPgS-bound Gas (PDB code: 1AZT) was used as the initial model. The structure was manually refined with Coot (Emsley et al., 2010) and PHENIX (Adams et al., 2010) . Data collection and refinement statistics can be found in Table S1 (related to Figure 2 ). In the Ramachandran plot of the final structure, 97.64% and 2.06% of the residues are in the favored regions and allowed regions, respectively, while one residue, V65 in a loop, is calculated as an outlier.
QUANTIFICATION AND STATISTICAL ANALYSIS
The curves in Figures 1A-1C, 1E , 3B, 3C, 5C, 5D, 6B-6E, S1C, S2A-S2C, and S5 were fitted by GraphPad Prism. The data in Figure 6A was analyzed by Excel. All the details can be found in the figure legends of these figures and in the METHOD DETAILS. The data collection and refinement statistics of the crystal structure of the GDP-bound Gas(R201C/C237S) can be found in Table S1 (related to Figure 2 ).
DATA AND SOFTWARE AVAILABILITY
Data Resources
The accession number for the crystal structure of GDP-bound Gas(R201C/C237S) reported in this paper is PDB: 6AU6.
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